Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.
Linda Rodgers-Fouche, Sanjeevani Arora, Charité Ricker, Dan Li, Maheen Farooqi, Francesc Balaguer, Mev Dominguez-Valentin, Jose G Guillem, Priyanka Kanth, David Liska, Joshua Melson, Kathryn A Mraz, Brian H Shirts, Eduardo Vilar, Bryson W Katona
September 2023 JCO Precis OncolSynopsis of Social media discussions
The overall tone reflects a strong consensus supporting the article's findings, with some posts citing high statistics like '70% of CRC experts support germline testing,' emphasizing its significance. The use of positive words such as 'love' and supportive phrases like 'support' reflect enthusiasm, while references to 'systematic implementation' highlight the perceived high impact of the publication on clinical care.
Agreement
Strong agreementMost discussions strongly support the article, emphasizing the importance of universal germline testing in colorectal cancer as reflected by phrases like 'support #universal #germline #genetic testing for all #patients' and '150K #patients diagnosed...sup
Interest
Moderate level of interestThe discussions show moderate interest, with some posts highlighting statistics about colorectal cancer prevalence and technical aspects, indicating engagement but not intense curiosity.
Engagement
Moderate level of engagementPosts reference specific data points and express approval, but lack in-depth analysis or critical debate, suggesting moderate engagement rather than deep discussion.
Impact
High level of impactThe discussions underscore the potential of the publication to influence clinical practices worldwide, with mentions of systematic implementation and widespread support, indicating high perceived impact.
Social Mentions
YouTube
2 Videos
14 Posts
Metrics
Video Views
17
Total Likes
46
Extended Reach
33,289
Social Features
16
Timeline: Posts about article
Top Social Media Posts
Ed Esplin, MD, PhD
150K #patients diagnosed w/ #CRC/year
1.5M #patients living with #CRC in the US
>70% of #CRC experts support #universal #germline #genetictesting for all #patients w/ #colorectalcancer
Now for systematic implementation
https://t.co/kAH3qrMDoC @JCOPO_ASCO @CGAIGC
c/w https://t.co/cOLjNmzUdF
view full post
JCO Precision Oncology
view full post
Gastrointestinal and Pancreatic Oncology Team
view full post
JCO Precision Oncology
‼️ #CGAIGC23 Simultaneous Publication in #JCOPO by Linda Rodgers-Fouche, MGC, CGC et al: Exploring Stakeholders’ Perspectives on Implementing Universal #GermlineTesting for Colorectal Cancer: Findings From a Clinical Practice Survey ➡️ https://t.co/L4T4D8OKwK #crcsm https://t.co/myf0t0F6pB
view full post
JCO Precision Oncology
view full post
Posts referencing the article
Implementing Universal Germline Testing for Colorectal Cancer in Clinical Practice
Drs Shaalan Beg and Priyanka Kanth discuss the readiness, logistics, and barriers to implementing universal germline multigene panel testing for colorectal cancer following new NCCN guidelines for patients under 50. They also explore addressing unmet needs as new data emerges.
April 8, 2024
11 views
Implementing Universal Germline Testing for Colorectal Cancer: Stakeholder Insights
Most participants support implementing universal germline testing for colorectal cancer patients, with 73% in favor. Key barriers include limited genetics knowledge among providers, time constraints, and insurance issues.
April 3, 2024
6 views
-
December 13, 2023
11
5
-
Roberta Horgan
@HorganRoberta (Twitter)RT @CGAIGC: Love that something #CGAIGC related is officially
view full postNovember 5, 2023
1
-
CGA-IGC
@CGAIGC (Twitter)Love that something #CGAIGC related is officially
view full postNovember 4, 2023
4
1
-
lynch syndrome irl @lsireland.bsky.social
@Lynchsyndromirl (Twitter)Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey https://t.co/cEXREY3z4z
view full postNovember 4, 2023
1
-
Antoni Castells
@castells_toni (Twitter)RT @OGIPclinic:
view full postNovember 3, 2023
1
-
JCO Precision Oncology
@JCOPO_ASCO (Twitter)November 3, 2023
4
-
lynch syndrome irl @lsireland.bsky.social
@Lynchsyndromirl (Twitter)RT @EdEsplin: 150K #patients diagnosed w/ #CRC/year 1.5M #patients living with #CRC in the US >70% of #CRC experts support #universal #ger…
view full postOctober 30, 2023
5
-
Gastrointestinal and Pancreatic Oncology Team
@OGIPclinic (Twitter)October 30, 2023
6
1
-
Zach Yeung MD
@zpyeung (Twitter)RT @EdEsplin: 150K #patients diagnosed w/ #CRC/year 1.5M #patients living with #CRC in the US >70% of #CRC experts support #universal #ger…
view full postOctober 29, 2023
5
-
OncoPapers
@sccancerres (Twitter)RT @EdEsplin: 150K #patients diagnosed w/ #CRC/year 1.5M #patients living with #CRC in the US >70% of #CRC experts support #universal #ger…
view full postOctober 29, 2023
5
-
ana
@anasajoo (Twitter)RT @EdEsplin: 150K #patients diagnosed w/ #CRC/year 1.5M #patients living with #CRC in the US >70% of #CRC experts support #universal #ger…
view full postOctober 29, 2023
5
-
Ed Esplin, MD, PhD
@EdEsplin (Twitter)150K #patients diagnosed w/ #CRC/year 1.5M #patients living with #CRC in the US >70% of #CRC experts support #universal #germline #genetictesting for all #patients w/ #colorectalcancer Now for systematic implementation https://t.co/kAH3qrMDoC @JCOPO_ASCO @CGAIGC c/w https://t.co/cOLjNmzUdF
view full postOctober 29, 2023
15
5
-
Asaf Maoz
@asaf_maoz (Twitter)RT @JCOPO_ASCO: ‼️ #CGAIGC23 Simultaneous Publication in #JCOPO by Linda Rodgers-Fouche, MGC, CGC et al: Exploring Stakeholders’ Perspectiv…
view full postOctober 28, 2023
1
-
JCO Precision Oncology
@JCOPO_ASCO (Twitter)‼️ #CGAIGC23 Simultaneous Publication in #JCOPO by Linda Rodgers-Fouche, MGC, CGC et al: Exploring Stakeholders’ Perspectives on Implementing Universal #GermlineTesting for Colorectal Cancer: Findings From a Clinical Practice Survey ➡️ https://t.co/L4T4D8OKwK #crcsm https://t.co/myf0t0F6pB
view full postOctober 28, 2023
5
1
Abstract Synopsis
- Most participants support implementing universal germline testing (UGT) for colorectal cancer patients, with 73% in favor.
- Key barriers include limited genetics knowledge among non-genetics providers, time-consuming procedures, and insurance coverage issues.
- While there's strong support, many respondents believe practice changes are necessary and could be challenging to put into place.
JCO Precision Oncology
@JCOPO_ASCO (Twitter)